Miller Vincent A. 4
4 · Revolution Medicines, Inc. · Filed Sep 30, 2020
Insider Transaction Report
Form 4
Miller Vincent A.
Director
Transactions
- Sale
Common Stock
2020-09-28$34.11/sh−5,300$180,772→ 26,833 total - Sale
Common Stock
2020-09-29$34.07/sh−450$15,332→ 26,383 total
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $34.00 to $34.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 1,808 Restricted Stock Units.
- [F4]The transaction was executed in multiple trades in prices ranging from $34.00 to $34.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.